Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy

Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy

Patients with prostate cancer (PCa) on androgen-deprivation therapy (ADT) are at high risk of osteoporosis and fragility fractures. We aimed to provide some practical insights into the delivery of optimal bone health care for PCa patients, particularly those on ADT. An interdisciplinary group of e...

Full description

Bibliographic Details
Main Authors:	Enrique Casado, Angel Borque-Fernando, Manuel Caamaño, Jenaro Graña, Jesús Muñoz-Rodríguez, Juan Morote
Format:	Article
Language:	English
Published:	Korean Society for Sexual Medicine and Andrology 2022-01-01
Series:	The World Journal of Men's Health
Subjects:	androgen antagonists denosumab diphosphonates osteoporosis prostatic neoplasms

Similar Items

Long-Term Treatment of Postmenopausal Osteoporosis
by: Jacques P. Brown
Published: (2021-06-01)

Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
by: Lianghai Jiang, et al.
Published: (2022-11-01)

Impact of Monthly 120 Mg Denosumab on Bone Metabolism in Bone-metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
by: Jimpei Miyakawa, et al.
Published: (2017-06-01)

Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
by: Yong-Ki Min
Published: (2015-03-01)

Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
by: Mateus Bringel Oliveira Duarte, et al.
Published: (2021-11-01)

Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
by: Ji-Heh Park, et al.
Published: (2017-04-01)

Adherence of bisphosphonate and decreased risk of clinical vertebral fracture in osteoporotic patients: A propensity score matching analysis
by: Seihee Kim, et al.
Published: (2022-09-01)

Denosumab for the treatment of HIV-associated osteoporosis with fractures in a premenopausal woman
by: E. Marasco, et al.
Published: (2021-04-01)

Diagnosis and management of osteoporosis in the older senior
by: Sheryl F Vondracek, et al.
Published: (2009-03-01)

Osteoporosis in men: epidemiology and treatment with denosumab
by: Sidlauskas KM, et al.
Published: (2014-04-01)

Duration of treatment for osteoporosis
by: Luca Idolazzi, et al.
Published: (2013-03-01)

Transient osteoporosis of the hip and subclinical hypothyroidism: an unusual dangerous duet? Case report and pathogenetic hypothesis
by: Marco Paoletta, et al.
Published: (2020-08-01)

Problems in patient management and the impact of osteoporosis therapy on the incidence of clinical infection
by: O. M. Lesnyak, et al.
Published: (2021-07-01)

Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO)
by: Christian Meier, et al.
Published: (2017-08-01)

Risk factors for bone loss with prostate cancer in Korean men not receiving androgen deprivation therapy
by: Sun-Ouck Kim, et al.
Published: (2009-04-01)

Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates
by: Gu T, et al.
Published: (2016-02-01)

Optimization of osteoporosis and osteopenia management among renal transplant recipients
by: Mohammed K. Afifi, et al.
Published: (2021-11-01)

Periapical status in patients affected by osteoporosis: A retrospective clinical study
by: Erika Cadoni, et al.
Published: (2022-10-01)

Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy
by: Ning Zhang, et al.
Published: (2020-05-01)

Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
by: Takako Suzuki, et al.
Published: (2017-06-01)

Severe idiopathic osteoporosis in a premenopausal woman: A case for dual therapy
by: Sudarsanababu Lalitha Soumya, et al.
Published: (2020-01-01)

Effectiveness and safety of pamidronate treatment in nonambulatory children with low bone mineral density
by: Myeongseob Lee, et al.
Published: (2024-02-01)

Evaluation of Patient Satisfaction, Back Pain, and Bone Mineral Densitometry T-Scores in Patients with Postmenopausal Osteoporosis Who Received Denosumab Treatment
by: Gonca Sağlam, et al.
Published: (2021-12-01)

Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
by: Jia-Feng Chen, et al.
Published: (2019-10-01)

Long-term consequences of osteoporosis therapy with denosumab
by: Francisco Bandeira, et al.
Published: (2022-12-01)

Denosumab treatment in patients with different courses of osteoporosis
by: Liudmila Ya. Rozhinskaya, et al.
Published: (2017-12-01)

Correction: Efficacy of Denosumab in the Treatment of Postmenopausal Osteoporosis: One-year Follow-up, Single Center Study
by: İsmail Tunçekin, et al.
Published: (2023-12-01)

Denosumab for the treatment of osteoporosis
by: Michael R. McClung
Published: (2017-03-01)

Denosumab – a new medication in the treatment of postmenopausal osteoporosis
by: Radosław Słopień, et al.
Published: (2017-10-01)

Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
by: Chuanjian Yuan, et al.
Published: (2023-06-01)

Treatment of primary osteoporosis in men
by: Giusti A, et al.
Published: (2014-12-01)

Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis
by: Arina Miyoshi, et al.
Published: (2021-07-01)

Assessing salivary matrix metalloproteinase‐8 in prostate cancer patients undergoing androgen deprivation therapy
by: Maaz A. Memon, et al.
Published: (2022-10-01)

USE OF TERIPARATIDE IN SURGICAL PLANNING FOR PATIENTS WITH OSTEOPOROSIS
by: RICARDO CEPEDA JORDAN, et al.
Published: (2023-10-01)

The efficacy of denosumab in Korean male patients with osteoporosis
by: Chaiho Jeong, et al.
Published: (2022-09-01)

Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study
by: Chaiho Jeong, et al.
Published: (2023-04-01)

Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis
by: Filippo Migliorini, et al.
Published: (2021-08-01)

Efficacy of denosumab therapy for neurofibromatosis type I with osteoporosis and history of fractures: a case report
by: Uehara M, et al.
Published: (2018-07-01)

OSTEOPOROSIS AND JOINT REPLACEMENT
by: Holzer Gerold, et al.
Published: (2018-08-01)

Effectiveness of Denosumab in Postmenopausal Osteoporosis Treatment: A 1-yr Follow-up Single-center Study
by: Nihal Tezel, et al.
Published: (2021-12-01)